Ostrobothnia Digital Clinic Experiment

NCT06904469 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170306

Last updated 2025-08-20

No results posted yet for this study

Summary

This randomized controlled trial (RCT) examines the impacts of a publicly provided digital clinic that offers digital primary care services to consumers. This intervention grants access to a public digital clinic that provides chat-based primary care consultations via a mobile phone application and website, including care needs assessment, diagnoses, follow-up care recommendations, and prescriptions. The digital clinic supplements traditional public primary care services, including in-person visits and phone consultations. The trial takes place in Ostrobothnia, Finland, a healthcare district serving a population of 178,000 residents. The investigators will randomize access to the digital clinic at the household level, providing access to 50% of the households. By doing so, the investigators aim to evaluate whether digital services can substitute for, complement, or increase the utilization of traditional primary care, particularly in-person visits or calls to traditional clinics. At the end of the nine-month trial, access to the digital clinic will be expanded to the entire population.

Conditions

  • Primary Care Provider

Interventions

OTHER

Access to a digital clinic

This intervention grants access to a digital clinic that provides chat-based primary care consultations via phone application and website.

Sponsors & Collaborators

  • Aalto University

    collaborator OTHER
  • University of Turku

    collaborator OTHER
  • Finnish Institute for Health and Welfare

    lead OTHER_GOV

Principal Investigators

  • Mika T Kortelainen, PhD · University of Turku and Finnish Institute for Health and Welfare

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2026-01-14
Completion
2026-01-14

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06904469 on ClinicalTrials.gov